Market Place
Sourcing Support
All News #Library
Others
Zhejiang Hisun Pharmaceutical Free of COVID-19, Gov Suggest Favipiravir
30 Jun 2020 //
PRNEWSWIRE
Zhejiang Hisun Pharma Free of COVID-19, Governments Suggest Favipiravir
26 Jun 2020 //
PRNEWSWIRE
Zhejiang Hisun Pharma Free of COVID-19, Governments Suggest Favipiravir
26 Jun 2020 //
PRNEWSWIRE
Zhejiang Hisun Pharma Les gouvernements recommandent le Favipiravir
26 Jun 2020 //
BUSINESSWIRE
Zhejiang Hisun Pharmaceutical Co.Free of COVID-19, Governments Favipiravir
26 Jun 2020 //
BUSINESSWIRE
Zhejiang Hisun shows positive effect of Favipiravir on COVID-19
20 Mar 2020 //
BIOSPECTRUMASIA
Zhejiang Hisun Pharma Favipiravir Works - Preliminary Clinical Studies COVID-19
19 Mar 2020 //
PRNEWSWIRE
Zhejiang Hisun Pharma gets approval for trial to test flu drug Favipiravir
17 Mar 2020 //
REUTERS
Favilavir approved as experimental coronavirus drug
22 Feb 2020 //
PHARMACEUTICAL TECHNOLOGY
China approves first anti-viral drug against coronavirus Covid-19
18 Feb 2020 //
CLINICALTRIALSARENA
PAG infuses $540M to gain control of Hisun`s biosimilar subsidiary
06 Sep 2019 //
ENDPTS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.